ID   MUC4_RAT                Reviewed;        2344 AA.
AC   Q63661; Q63655; Q63657; Q63659; Q9JIC4;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 2.
DT   24-JUL-2024, entry version 119.
DE   RecName: Full=Mucin-4;
DE            Short=MUC-4;
DE   AltName: Full=Ascites sialoglycoprotein;
DE            Short=ASGP;
DE   AltName: Full=Pancreatic adenocarcinoma mucin;
DE   AltName: Full=Pre-sialomucin complex;
DE            Short=pSMC;
DE   AltName: Full=Sialomucin complex;
DE   AltName: Full=Testis mucin;
DE   Contains:
DE     RecName: Full=Mucin-4 alpha chain;
DE     AltName: Full=Ascites sialoglycoprotein 1;
DE              Short=ASGP-1;
DE   Contains:
DE     RecName: Full=Mucin-4 beta chain;
DE     AltName: Full=Ascites sialoglycoprotein 2;
DE              Short=ASGP-2;
DE   Flags: Precursor;
GN   Name=Muc4; Synonyms=Smc;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Fischer 344;
RX   PubMed=8163496; DOI=10.1016/s0021-9258(17)32665-0;
RA   Wu K., Fregien N., Carraway K.L.;
RT   "Molecular cloning and sequencing of the mucin subunit of a heterodimeric,
RT   bifunctional cell surface glycoprotein complex of ascites rat mammary
RT   adenocarcinoma cells.";
RL   J. Biol. Chem. 269:11950-11955(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-30.
RX   PubMed=10880365; DOI=10.1042/0264-6021:3490641;
RA   Price-Schiavi S.A., Perez A., Barco R., Carraway K.L.;
RT   "Cloning and characterization of the 5' flanking region of the sialomucin
RT   complex/rat Muc4 gene: promoter activity in cultured cells.";
RL   Biochem. J. 349:641-649(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1601-2344, AND GLYCOSYLATION.
RC   STRAIN=Fischer 344;
RX   PubMed=1379596; DOI=10.1016/s0021-9258(18)42007-8;
RA   Sheng Z., Wu K., Carraway K.L., Fregien N.;
RT   "Molecular cloning of the transmembrane component of the 13762 mammary
RT   adenocarcinoma sialomucin complex. A new member of the epidermal growth
RT   factor superfamily.";
RL   J. Biol. Chem. 267:16341-16346(1992).
RN   [4]
RP   SUBUNIT, SUBCELLULAR LOCATION, TOPOLOGY, AND PROTEOLYTIC CLEAVAGE.
RX   PubMed=7440586; DOI=10.1016/s0021-9258(19)70243-9;
RA   Sherblom A.P., Carraway K.L.;
RT   "A complex of two cell surface glycoproteins from ascites mammary
RT   adenocarcinoma cells.";
RL   J. Biol. Chem. 255:12051-12059(1980).
RN   [5]
RP   POST-TRANSCRIPTIONAL REGULATION.
RX   PubMed=9857062; DOI=10.1074/jbc.273.52.35228;
RA   Price-Schiavi S.A., Carraway C.A., Fregien N., Carraway K.L.;
RT   "Post-transcriptional regulation of a milk membrane protein, the sialomucin
RT   complex (Ascites sialoglycoprotein (ASGP)-1/ASGP-2, rat muc4), by
RT   transforming growth factor beta.";
RL   J. Biol. Chem. 273:35228-35237(1998).
RN   [6]
RP   INTERACTION WITH ERBB2; ERBB3 AND NRG1, AND PHOSPHORYLATION OF ERBB2.
RX   PubMed=12386815; DOI=10.1038/sj.onc.1205970;
RA   Jepson S., Komatsu M., Haq B., Arango M.E., Huang D., Carraway C.A.,
RA   Carraway K.L.;
RT   "Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific
RT   phosphorylation of ErbB2 and enhances expression of p27(kip), but does not
RT   activate mitogen-activated kinase or protein kinaseB/Akt pathways.";
RL   Oncogene 21:7524-7532(2002).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15672420; DOI=10.1002/jcp.20277;
RA   Zhang J., Perez A., Yasin M., Soto P., Rong M., Theodoropoulos G.,
RA   Carothers Carraway C.A., Carraway K.L.;
RT   "Presence of MUC4 in human milk and at the luminal surfaces of blood
RT   vessels.";
RL   J. Cell. Physiol. 204:166-177(2005).
RN   [8]
RP   INTERACTION WITH ERBB2 AND ERBB3.
RX   PubMed=16624867; DOI=10.1091/mbc.e05-09-0895;
RA   Ramsauer V.P., Pino V., Farooq A., Carothers Carraway C.A., Salas P.J.,
RA   Carraway K.L.;
RT   "Muc4-ErbB2 complex formation and signaling in polarized Caco-2 epithelial
RT   cells indicate that Muc4 acts as an unorthodox ligand for ErbB2.";
RL   Mol. Biol. Cell 17:2931-2941(2006).
CC   -!- FUNCTION: Membrane-bound mucin, a family of highly glycosylated
CC       proteins that constitute the major component of the mucus, the slimy
CC       and viscous secretion covering epithelial surfaces. These glycoproteins
CC       play important roles in the protection of the epithelium and are
CC       implicated in epithelial renewal and differentiation. Regulates
CC       cellular behavior through both anti-adhesive effects on cell-cell and
CC       cell-extracellular matrix interactions and its ability to act as an
CC       intramembrane ligand for ERBB2. Plays an important role in
CC       proliferation and differentiation of epithelial cells by inducing
CC       specific phosphorylation of ERBB2. In polarized epithelial cells,
CC       segregates ERBB2 and other ERBB receptors and prevents ERBB2 from
CC       acting as a coreceptor. The interaction with ERBB2 leads to enhanced
CC       expression of CDKN1B. The formation of a MUC4-ERBB2-ERBB3-NRG1 complex
CC       leads to down-regulation of CDKN1B, resulting in repression of
CC       apoptosis and stimulation of proliferation. Its ability to promote
CC       tumor growth may be mainly due to repression of apoptosis as opposed to
CC       proliferation. {ECO:0000250|UniProtKB:Q99102}.
CC   -!- SUBUNIT: A heterodimeric complex, composed of a mucin-4 alpha chain and
CC       a cysteine-rich transmembrane mucin-4 beta chain (PubMed:7440586).
CC       Mucin-4 beta chain interacts with ERBB2 via the EGF-like domain 1. In
CC       nonpolarized cells, associates with ERBB2 and ERBB3 (PubMed:12386815,
CC       PubMed:16624867). {ECO:0000269|PubMed:12386815,
CC       ECO:0000269|PubMed:16624867, ECO:0000269|PubMed:7440586}.
CC   -!- SUBCELLULAR LOCATION: [Mucin-4 beta chain]: Cell membrane
CC       {ECO:0000305|PubMed:7440586}; Multi-pass membrane protein
CC       {ECO:0000305|PubMed:7440586}.
CC   -!- SUBCELLULAR LOCATION: [Mucin-4 alpha chain]: Secreted
CC       {ECO:0000305|PubMed:7440586}. Note=Secreted by proteolytic processing.
CC       {ECO:0000305|PubMed:7440586}.
CC   -!- TISSUE SPECIFICITY: Expression is developmentally regulated in the
CC       mammary gland, dramatically increases in the lactating gland compared
CC       with the virgin mammary gland, while decreasing again during mammary
CC       gland involution. Expressed in 13762 ascites cells. Overexpressed in
CC       some aggressive mammary tumors. Overexpression seems to block cell-cell
CC       and cell-matrix interactions to protect tumor cells from immune
CC       surveillance, and to promote metastasis.
CC   -!- DOMAIN: [Mucin-4 alpha chain]: Essentially composed of an array of
CC       serine- and threonine-rich tandem repeats which is highly polymorphic,
CC       the variable number of tandem repeats (VNTR) region.
CC       {ECO:0000250|UniProtKB:Q99102}.
CC   -!- PTM: Proteolytically cleaved into 2 subunits, mucin-4 alpha chain and
CC       mucin-4 beta chain. {ECO:0000305|PubMed:7440586}.
CC   -!- PTM: Mucin-4 alpha subunit is highly O-glycosylated.
CC       {ECO:0000269|PubMed:1379596}.
CC   -!- PTM: Mucin-4 beta subunit is predominantly N-glycosylated.
CC       {ECO:0000269|PubMed:1379596}.
CC   -!- POLYMORPHISM: The variable number of tandem repeats (VNTR) region, an
CC       array of serine- and threonine-rich tandem repeats, is encoded by a
CC       single exon (exon 2) which is highly polymorphic. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U06746; AAA85517.1; -; mRNA.
DR   EMBL; U06748; AAA85519.1; -; mRNA.
DR   EMBL; U06750; AAA85521.1; -; mRNA.
DR   EMBL; U06752; AAA85523.1; -; mRNA.
DR   EMBL; AF240632; AAF86958.1; -; Genomic_DNA.
DR   PIR; A43353; A43353.
DR   PIR; A53577; A53577.
DR   AlphaFoldDB; Q63661; -.
DR   GlyCosmos; Q63661; 27 sites, No reported glycans.
DR   GlyGen; Q63661; 27 sites.
DR   PhosphoSitePlus; Q63661; -.
DR   UCSC; RGD:621331; rat.
DR   AGR; RGD:621331; -.
DR   RGD; 621331; Muc4.
DR   InParanoid; Q63661; -.
DR   Reactome; R-RNO-913709; O-linked glycosylation of mucins.
DR   Reactome; R-RNO-977068; Termination of O-glycan biosynthesis.
DR   PRO; PR:Q63661; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0031528; C:microvillus membrane; IDA:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0005176; F:ErbB-2 class receptor binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:InterPro.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:RGD.
DR   GO; GO:0048565; P:digestive tract development; IEP:RGD.
DR   GO; GO:0044849; P:estrous cycle; IEP:RGD.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; ISO:RGD.
DR   GO; GO:0007595; P:lactation; IEP:RGD.
DR   GO; GO:0030277; P:maintenance of gastrointestinal epithelium; ISO:RGD.
DR   GO; GO:0030879; P:mammary gland development; IEP:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:RGD.
DR   GO; GO:0022408; P:negative regulation of cell-cell adhesion; IDA:RGD.
DR   GO; GO:0001953; P:negative regulation of cell-matrix adhesion; IDA:RGD.
DR   GO; GO:0002853; P:negative regulation of T cell mediated cytotoxicity directed against tumor cell target; IDA:RGD.
DR   GO; GO:0031077; P:post-embryonic camera-type eye development; IEP:RGD.
DR   GO; GO:0034097; P:response to cytokine; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0033189; P:response to vitamin A; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   CDD; cd00053; EGF; 1.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR051495; Epithelial_Barrier/Signaling.
DR   InterPro; IPR003886; NIDO_dom.
DR   InterPro; IPR001846; VWF_type-D.
DR   PANTHER; PTHR13802; MUCIN 4-RELATED; 1.
DR   PANTHER; PTHR13802:SF65; MUCIN-4; 1.
DR   Pfam; PF06119; NIDO; 1.
DR   Pfam; PF00094; VWD; 1.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00539; NIDO; 1.
DR   SMART; SM00216; VWD; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS51220; NIDO; 1.
DR   PROSITE; PS51233; VWFD; 1.
PE   1: Evidence at protein level;
KW   Cell adhesion; Cell membrane; Disulfide bond; EGF-like domain;
KW   Glycoprotein; Membrane; Reference proteome; Repeat; Secreted; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..30
FT                   /evidence="ECO:0000255"
FT   CHAIN           31..2344
FT                   /note="Mucin-4"
FT                   /id="PRO_0000274230"
FT   CHAIN           31..1615
FT                   /note="Mucin-4 alpha chain"
FT                   /evidence="ECO:0000305|PubMed:7440586"
FT                   /id="PRO_0000274231"
FT   CHAIN           1616..2344
FT                   /note="Mucin-4 beta chain"
FT                   /evidence="ECO:0000305|PubMed:7440586"
FT                   /id="PRO_0000274232"
FT   TRANSMEM        2173..2193
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2301..2321
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          1332..1492
FT                   /note="NIDO"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00570"
FT   DOMAIN          1609..1804
FT                   /note="VWFD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00580"
FT   DOMAIN          2047..2086
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          2256..2295
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REGION          32..760
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          81..1006
FT                   /note="Variable number of tandem repeats (VNTR)"
FT                   /evidence="ECO:0000305"
FT   REGION          773..1036
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1072..1130
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1171..1197
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1233..1269
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1574..1597
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        32..367
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        376..760
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1233..1266
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1582..1597
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            1616..1617
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000305|PubMed:7440586"
FT   CARBOHYD        133
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        391
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        392
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        470
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        479
FT                   /note="O-linked (GalNAc...) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1644
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1660
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1672
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1689
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1698
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1704
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1715
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1724
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1759
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1780
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1787
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1829
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1874
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1926
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1951
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1974
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1981
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2029
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2048
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2114
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2121
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2227
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        2051..2062
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2056..2074
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2076..2085
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2259..2270
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2264..2279
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2281..2294
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   CONFLICT        81
FT                   /note="I -> L (in Ref. 1; AAA85519/AAA85521)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        92
FT                   /note="S -> G (in Ref. 1; AAA85519/AAA85521)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        103..104
FT                   /note="GT -> RN (in Ref. 1; AAA85519/AAA85521)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        110
FT                   /note="T -> A (in Ref. 1; AAA85521)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        126..127
FT                   /note="QT -> RA (in Ref. 1; AAA85521)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        128
FT                   /note="T -> A (in Ref. 1; AAA85519)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        133
FT                   /note="T -> A (in Ref. 1; AAA85521)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        141..143
FT                   /note="RES -> ER (in Ref. 1; AAA85519)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        150..485
FT                   /note="Missing (in Ref. 1; AAA85519)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        156
FT                   /note="T -> M (in Ref. 1; AAA85521)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        170
FT                   /note="M -> T (in Ref. 1; AAA85521)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        174
FT                   /note="T -> V (in Ref. 1; AAA85521)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        490
FT                   /note="G -> V (in Ref. 1; AAA85519)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        498
FT                   /note="T -> K (in Ref. 1; AAA85519)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        501..502
FT                   /note="VT -> IS (in Ref. 1; AAA85519)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        505
FT                   /note="D -> G (in Ref. 1; AAA85519)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2344 AA;  248041 MW;  0182776F4FDE997F CRC64;
     MRGPHGVSWR VPWLCLSCLC SCLLLLPVNT STTSAPKTST ALPSSTNPSQ MTSQVSNPTA
     SSYRMTKNTG QASPMVTSSS ITTLPQSQHT GSMKTTRNPQ TTGTTEVTTT LSASSSDQVQ
     VETTSQTTLS PDTTTTSHAP RESSSPPSTS VILTTTASTE GTSGDTGHTM AVTTQGSTPA
     TTEISVTPST QKMSPVSTFS TSTQEITTLS QSQHTGGMKT TRNPQTTGTT EVTTTLSASS
     SDHPTSSPES TPGNTAPRTT ETSTTTTTKV LMTSLQQKLP TGSTLGTSTQ ELTTLPQSQH
     TGIMKTTSRT QTTTPTEVTT RTLSASSSDH RQAETSSQTT LSPDTTTTSH APRESSPPST
     SVILTHGHRE GTSGDTGHTM AVTTQGSTPA TTEISVTPST QKMSPVSTFS TSTQEITTLS
     QSQHTGGMKT TRNPQRTTPT EVTTSTLSAS SSDQVQVETT SRATLSPDTT TTSHAPSVSS
     SSPSPPSTEG TSVDTGLTTA VTTQDSTPAT TQGSLTSSSQ TLSTVSPLST STQETSTQEL
     TSSQSQHTGS MKTTHNPQTT RNTEVTTTLS ASSSDQVQVE TTSQTTLSDA TTTSHAPRES
     SSPPSTSDIL TTMASTEGTS GDTGHTMAVT TQGSTPATTE ISVTPSTQKM SPVSTFSTST
     QEITTLSQSQ HTGGMKTTRN PQTTGTTEVT TTLSASSSDQ VQAETSSQTT LSPDTTTTSH
     APRESSSPPS TSDMLTTTAS TEGTSGDTGH TTAVTTQGSI PATTQLSTTF ASQKMSTVST
     PTTSSIQELS TLPQSQHTGS MEISSRPQTT SVTSTLSSSP SGSTPVQTRS VTSSSDERTN
     PTSSGVSNTS PATTEVLTPT SSPESTPGNT APRTTETSTT TTTKVLMTSL QQKLPTGSTL
     GTSTPTEVTT TLSASSSDQV QVETTSQTTL SPDATTTSHA PRESSSPPST SVILTTMAST
     EGTSGDTGHT TAVTDQGSTP ATTEISVTPS TQKMSTVSTL VTSTQELTSS QSQRTGSMGT
     SSKPQATTPT EVTTSTLSSF SRGSLFSARN CCLQTKKPPL PAVVCLPDPS SVPSLMHSSK
     PQATTPTEVT TSTLSSFSRG STQTQTVSWE TSSSGKITAP STSSRRTPSV ATSDIFTTTD
     STSGNAGHTL LTGSHSVITS RVASTTLGRL STVAHRQSTQ RSSTHSQSYL TESMGASSTS
     ETSLLTEATT ETSLCLFTWT HCDRDLLSWT SSSGLTTKTD NDRSTALSAT SLTLPAPSTS
     TASRSTVPPA PLPPDQGISL FQIGFPLGSL CGIPSILQIT VRSFSPSQTT MSSPTPTHLK
     EASQEGSVCH SGHSGVMLIS LAPGEPYFRT TTSHFTMSST SLIRKVESLI NEFTSDWSFK
     PSDTEVTWVN VPAYPAQGRT LGANTYQAIL STDGSRSYAL FLYQSGGMRW DVTQGLYNRV
     LMGFSSGDGY FENSPLIFRP AVEKYRPDRF LTPNYGSGDS RSTGYTGRCG PTTGSSVCSG
     WKVSLSSPAG AGTRFPALAP GSRDFGSGSS TQVCGAGSYA ASLRAGRVLY VWHLGEFREG
     WRMHSPWQFD EDEGRHRTGL AAGTTSPLSA SSTSSGGPEL VVLGTRPPRP AWTFGDPHIT
     TLDNAKYTFN GLGYFLLVQA QDRNSSFLLE GRTAQTDSAN ATNFIAFAAQ YNTSSLKSPI
     TVQWFLEPND TIRVVHNNQT VAFNTSDTED LPVFNATGVL LIQNGSQVSA NFDGTVTISV
     IALSNILHAS SSLSEEYRNH TKGLLGVWND NPEDDFRMPN GSTIPSNTSE ETLFHYGMTS
     ETNGIGLLGV RTDPLPSEFT PIFLSQLWNK SGAGEDLISG CNEDAQCKFD ILATGNRDIG
     QSTNSILRTF RHVNGTLNQY PPPIHYSSKI QAYKGREQWP LRSPATLRMS YSASPTSAVA
     FELFENGSLH VDTNIPRRTY LEILARDVKT NLSSVLQPET VACFCSKEEQ CLYNETSKEG
     NSSTEVTSCK CDGNSFGRLC EHSKDLCTEP CFPNVDCIPG KGCQACPPNM TGDGRHCVAV
     EISEFCQNHS CPVNYCYNHG HCDISGPPDC QPTCTCAPAF TGNRCFLAGN NFTPIIYKEL
     PLRTITLSLR EDENASNADV NASVANVLEN LDMRAFLSNS LVELIRTSPG APVLGKPIHH
     WKVVSHFKYR PRGPLIHYLN NQLISAVMEA FLLQARQERR KRSGEARKNV RFFPISRADV
     QDGMALNLSM LDEYFTCDGY KGYHLVYSPQ DGVTCVSPCS EGYCHNGGQC KHLPDGPQCT
     CATFSIYTSW GERCEHLSVK LGAFFGILFG ALGALLLLAI LACVVFHFCG CSMNKFSYPL
     DSEL
//
